IP Verse

Arginine And Its Use As A T Cell Modulator

Patent No. EP3525775 (titled "Arginine And Its Use As A T Cell Modulator") was filed by Institute FOR Research IN Biomedicine on Oct 12, 2017. The application was issued on Jun 7, 2023.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
HAMPTON KNOWLESMar 7, 2024D YOUNG
COHAUSZ & FLORACK PATENT UND RECHTSANWALTE PARTNERSCHAFTSGESELLSCHAFT MBBJan 25, 2024COHAUSZ & FLORACK

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3525775

INSTITUTE FOR RESEARCH IN BIOMEDICINE
Application Number
EP17791612A
Filing Date
Oct 12, 2017
Status
Revoked
Dec 20, 2024
Publication Date
Jun 7, 2023
External Links
Slate, Register , Google Patents